Orthostatic Hypotension: Blood-Pressure Drops on Standing and Care

Direct answer. Orthostatic hypotension, also called postural hypotension, is a fall in blood pressure associated with becoming upright. It can cause dizziness, weakness or fainting, but a low resting reading is a different finding. Clinical assessment checks the postural pattern, medicines and other contributors, and treats the cause where possible.

Evidence summary

Confidence is high in the condition distinctions and need for appropriate assessment. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.

What it is

Postural hypotension is a clinical pattern in which becoming upright is associated with a blood-pressure fall. NHS describes dizziness or fainting after a position change as possible symptoms. A low pressure at rest can exist without symptoms and is not, by itself, the same diagnosis. NHS low blood pressure.

Fainting has several possible causes. A postural description is useful information, but it does not exclude a rhythm problem, another medical cause or a different form of transient loss of consciousness. Assessment should consider the whole episode, including what happened before and after it. NICE CG109 transient loss of consciousness, updated 2023.

How it works

Standing shifts the circulatory demand, and the body normally adjusts pressure and heart rate. A clinician assesses whether that response is inadequate and whether a contributor is present. Medicines, age-related changes and other conditions can matter; a treatment plan should explain the suspected contributor rather than assign a cause from posture alone. NHS low blood pressure.

POTS is another syndrome associated with upright symptoms, but its defining clinical pattern differs. An accelerated pulse is not proof that blood pressure fell, and a pressure change is not proof of POTS. Both measurements and the symptom history have to be interpreted in context. NHS postural tachycardia syndrome.

The evidence-based treatments

NICE recommends using the initial history and assessment to identify suspected postural hypotension and refers to lying–standing measurement guidance. It also recommends further specialist cardiovascular assessment when suggestive symptoms are not confirmed by blood-pressure measurements. One inconclusive appointment should therefore not be treated as a rule-out for every recurring episode. NICE CG109 transient loss of consciousness, updated 2023.

Clinical testing may also investigate another explanation for symptoms. ECG, longer rhythm recording and cardiac imaging answer different questions and are selected for the history. An episode associated with palpitations or exertion can require attention beyond a resting cuff reading. NHLBI arrhythmia diagnosis.

The NHS guide describes cause-directed care, which may include clinician-led medication changes or support stockings. It should not be read as permission to discontinue an important drug or as evidence that every patient needs a medicine to raise pressure. NHS low blood pressure.

The plan should discuss fall risk, safe posture changes and any intake restrictions. Decisions about fluid, salt or compression need individual context where there is hypertension, heart failure, kidney disease or another contraindication. This article offers no personal intake target, pressure target or drug dose.

Supplement and lifestyle evidence

Discuss slower posture changes, avoiding relevant triggers and fall prevention as part of an individualized plan. A recommendation to improve hydration should account for any established fluid restriction; there is no universal salt-loading regimen in this guide.

No supplement is established here as a treatment for orthostatic hypotension. “Heart support,” improved vessel relaxation, a changed blood marker and fewer clinical events are different claims. The cited source set does not provide a fully financially screened trial basis for replacing diagnosis or prescribed care. Correcting a clinician-confirmed deficiency is a separate indication; a retail blend is not a diagnostic test or an emergency treatment.

What works and what does not

Useful care establishes whether symptoms correspond to a postural pressure change, explains possible contributors and gives a fall and follow-up plan. A single normal reading, a single low reading or a supplement response cannot settle every cause of fainting.

Ask which outcome is being pursued: symptoms, physiological findings, recurrence, hospital admission or survival. A plan should also say how adverse effects and deterioration will be recognized. Personal stories and before-and-after readings cannot separate treatment effects from the natural course, other medicines or selection of patients. Manufacturer or materially conflicted outcome claims do not determine this article’s independent verdict.

Risks and side effects

Emergency features include incomplete recovery, chest pain or palpitations with a faint, exertional fainting, significant injury, seizure-like activity or abnormal breathing. Do not attribute those features to a benign pressure drop without assessment. NHS fainting.

Medicines intended to change heart rate or rhythm can themselves cause troublesome symptoms or another rhythm problem. Procedures have risks that should be explained for the proposed intervention, including bleeding or damage associated with catheter procedures. The exact diagnosis, heart function and medicine combination matter. NHLBI arrhythmia treatment.

Important interactions

Some prescribed and non-prescribed products alter blood pressure, rate or fluid balance. The prescriber should review the full combination and the original reason for each medicine before a change. Do not share pressure-raising treatment or rescue drugs. NHLBI arrhythmia treatment.

Bring prescription medicines, non-prescription products, recreational drugs and supplements to the same medication review. Product names alone may hide several active ingredients. The prescriber or pharmacist should check the exact combination and kidney function, rather than treating “natural” as a safety category. Never add a second person’s rescue medicine or stop an important prescribed medicine because an internet list mentions a possible interaction.

Who needs assessment

Recurring symptoms, falls or a new problem after a medicine change warrant review. Tell the clinician about postural timing, meals, illness and what witnesses observed, including how quickly recovery occurred. NICE CG109 transient loss of consciousness, updated 2023.

A person with recurring symptoms needs a clear review route even when a brief earlier ECG was reassuring. Record the timing and circumstances for the clinician, rather than provoking another episode to prove what it is. NHLBI arrhythmia diagnosis.

Clinician-led use and follow-up

Agree how symptoms and relevant pressure measurements will be reassessed and what new features require earlier help. Ask about driving and hazardous activities after fainting according to local rules and the established cause. NICE CG109 transient loss of consciousness, updated 2023.

This guide gives no personal drug, device or supplement dose. The appropriate plan depends on the established diagnosis, current stability, other illnesses and local services. Ask for a written explanation of the treatment purpose, warning signs, review schedule and contact route for side effects. Clinical monitoring and informed consent should accompany any change; study exposures are not prescriptions.

Animal and in-vitro evidence

Cell and animal experiments on vessel function or cardiac stress can suggest mechanisms. They do not establish safe human dosing, symptom improvement or fewer serious events. A laboratory preparation and a retail product may differ in composition, absorption and exposure. No animal or in-vitro result contributes to the independent clinical verdict in this guide.

Funding and source roles

The financial stakes include ECG monitoring, electrophysiology services, antiarrhythmic medicines, implanted devices and ablation. Diagnostic yield, symptom relief and prevention of a serious event are distinct claims. No commercially supported efficacy result establishes the independent verdict in this guide.

The condition has no corporate owner. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.

Frequently asked questions

Is a low resting reading the same diagnosis?
No. Orthostatic hypotension concerns the response to posture. NHS low blood pressure.

What if the first measurement is inconclusive?
Suggestive recurring symptoms can require further assessment. NICE CG109 transient loss of consciousness, updated 2023.

Can I stop a blood-pressure medicine myself?
No. The reason for prescribing it and the proposed change need clinical review.

Can a rhythm problem cause similar symptoms?
Yes; the symptom history helps guide appropriate testing. NHLBI arrhythmia diagnosis.

Sources and funding notes

• NHS low blood pressure — Public postural symptoms and cause-directed care; July 2023.
• NICE CG109 transient loss of consciousness, updated 2023 — Attributed postural assessment and referral; updated 2023.
• NHS postural tachycardia syndrome — Distinct upright tachycardia syndrome.
• NHLBI arrhythmia diagnosis — ECG and other causes of episodic symptoms.
• NHLBI arrhythmia causes — Cardiac/systemic contributors.
• NHLBI arrhythmia treatment — Medication and rate/pressure risks.
• NHS fainting — Urgent fainting features.
• NHLBI arrhythmias — Additional original linked in condition-specific education or follow-up.
• NHLBI budget — Financial provenance only.
• NHLBI Gift Fund — Financial provenance only.
• NHS national website funding policy — Financial provenance only.

Original clinical pages and their relevant financial disclosures were opened. Where cited, the 2026 definition was read through the web tool; its author supplement was inaccessible and remains an explicit gap. Where cited, the 2018 SCAD papers were read in original full versions, including funding and disclosure tables. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.

Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.